Expression profiling of DNA methyl transferase I (DNMT1) and efficacy of a DNA-hypomethylating agent (decitabine) in combination with chemotherapy in osteosarcoma
© 2020 Background: Abnormality in the DNA methylation process is one of the hallmarks of cancer. Emerging evidence strongly supports the idea that defects in DNA methyl transferases (DNMTs) are involved in tumor development and progression. This alteration has major effects at the transcription leve...
Saved in:
Main Authors: | Parunya Chaiyawat, Nutnicha Sirikaew, Piyaporn Budprom, Jeerawan Klangjorhor, Areerak Phanphaisarn, Pimpisa Teeyakasem, Jongkolnee Settakorn, Dumnoensun Pruksakorn |
---|---|
Format: | Journal |
Published: |
2020
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85091985687&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/70742 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Expression patterns of class i histone deacetylases in osteosarcoma: A novel prognostic marker with potential therapeutic implications
by: Parunya Chaiyawat, et al.
Published: (2018) -
Mycophenolic acid is a drug with the potential to be repurposed for suppressing tumor growth and metastasis in osteosarcoma treatment
by: Jeerawan Klangjorhor, et al.
Published: (2020) -
Endoplasmic reticulum protein 29 (ERp29) as a novel prognostic marker and tumor suppressor in osteosarcoma
by: Parunya Chaiyawat, et al.
Published: (2019) -
In vitro drug sensitivity (IDS) of patient-derived primary osteosarcoma cells as an early predictor of the clinical outcomes of osteosarcoma patients
by: Jeerawan Klangjorhor, et al.
Published: (2020) -
Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma
by: Parunya Chaiyawat, et al.
Published: (2018)